Nordic completes Nycomed exit

CSFB’s private equity division has acquired Nordic Capital’s Danish pharmaceutical business in one of Europe’s largest secondary transactions.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this